Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EGFR | P00533 | 14/20 | 0.59 |
| ▸ | GAK | O14976 | 3/20 | 0.49 |
| ▸ | FBP1 | P09467 | 2/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.49 |
| ▸ | MAPT | P10636 | 1/20 | 0.49 |
| ▸ | ERBB2 | P04626 | 8/20 | 0.49 |
| ▸ | RIPK2 | O43353 | 2/20 | 0.48 |
| ▸ | BUB1 | O43683 | 2/20 | 0.48 |
| ▸ | STK10 | O94804 | 2/20 | 0.48 |
| ▸ | ABL1 | P00519 | 2/20 | 0.48 |
| ▸ | LCK | P06239 | 2/20 | 0.48 |
| ▸ | LYN | P07948 | 2/20 | 0.48 |
| ▸ | RET | P07949 | 2/20 | 0.48 |
| ▸ | SRC | P12931 | 2/20 | 0.48 |
| ▸ | FGFR2 | P21802 | 2/20 | 0.48 |
| ▸ | FECH | P22830 | 2/20 | 0.48 |
| ▸ | KDR | P35968 | 2/20 | 0.48 |
| ▸ | FLT3 | P36888 | 2/20 | 0.48 |
| ▸ | MAP3K1 | Q13233 | 2/20 | 0.48 |
| ▸ | PLK4 | O00444 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7578731 | 0.89 | EGFR (0.55) | EGFRALDH1A1MAPTERBB2KDR | |
| SCHEMBL7585049 | 0.88 | EGFR (0.58) | EGFRERBB2ERBB4MKNK1 | |
| SCHEMBL7584725 | 0.88 | ERBB2 (0.58) | EGFRFBP1ALDH1A1MAPTERBB2 | |
| SCHEMBL7843657 | 0.86 | EGFR (0.48) | EGFRGAKFBP1ALDH1A1MAPT | |
| SCHEMBL7582363 | 0.86 | EGFR (0.52) | EGFRGAKFBP1ALDH1A1MAPT | |
| SCHEMBL7574942 | 0.85 | EGFR (0.51) | EGFRGAKFBP1ALDH1A1MAPT | |
| SCHEMBL7585812 | 0.83 | ERBB2 (0.56) | EGFRFBP1ALDH1A1MAPTERBB2 | |
| SCHEMBL7855902 | 0.83 | EGFR (0.46) | EGFRGAKFBP1ALDH1A1MAPT | |
| SCHEMBL7586889 | 0.83 | EGFR (0.49) | EGFRGAKFBP1ALDH1A1MAPT | |
| SCHEMBL7855879 | 0.83 | EGFR (0.45) | EGFRGAKBRAF |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20020082420-A1 | Bicyclic heterocycles, pharmaceutical compositions containing them, their use, and processes for preparing them | BOEHRINGER INGELHEIM PHARMA KG (DE) | 2002-06-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020082420-A1 | Bicyclic heterocycles, pharmaceutical compositions containing them, their use, and processes for preparing them | PKD1, REN, CYP11B1 | EGFR 1041/4885GAK 2237/4885FBP1 1132/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.